Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

MANDOM

長谷川香料

ROHTO PHARMACEUTICAL

Toray Industries

Hitachi Chemical

TSUMURA & CO.

キッセイ薬品工業

ダイセル

東京応化工業

Sekisui Chemical

Nissan Chemical Industries

Takeda Pharmaceutical

千寿製薬

Kuraray

Dainippon Sumitomo Pharma

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nissan Motor

KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

ROHM

Renesas Electronics

Credit Rating Analysis: アステラス製薬 (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): アステラス製薬 (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	A	Credit is high, but affected by biz environs.	¥ 1.0 T 3.73%	¥ 157 B 16.31%	¥ 82 B 5.90%

Financial Timeline

Date	2012-12-31  (Third quarter )	2013-03-31  (Annual )	2013-06-30  (First quarter )	2013-09-30  (Second quarter )
Credit Rating	BBB	A	A	A
Total Assets	¥ 1.4 T	¥ 1.4 T	¥ 1.4 T	¥ 1.4 T
Net Assets	¥ 1.0 T	¥ 1.0 T	¥ 1.0 T	¥ 1.1 T

Financial Statement Risk Analysis: アステラス製薬 (Annual ) (Consolidated )

[Date: 2013-03-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -48 B) & Financial Cash Flow (¥ -109 B) is a minus, Operating Cash Flow (¥ 144 B) is a plus,

Dividend
Under the situation of Net Income (¥ 82 B) & Operating Cash Flow (¥ 144 B) , Dividend (¥ -60 B) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 1.0 T) is first term (¥ 969 B) more, however Operating Cash Flow (¥ 144 B) is first term (¥ 172 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -25 B) & Financial Cash Flow (¥ -57 B) is a minus, Operating Cash Flow (¥ 172 B) is a plus,

Dividend
Under the situation of Net Income (¥ 78 B) & Operating Cash Flow (¥ 172 B) , Dividend (¥ -57 B) is paid.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 59 B) is Sales first term ratio (¥ 15 B) more , there is a possibility that the non-performing asset was increased.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Management Risk (*Sales is decrease )
Sales (¥ 953 B) is first term Sales (¥ 974 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ 67 B) is first term Net Income (¥ 122 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (7.09％) is first term Net Profit Margin (12.54％) less , there is a possibility that the profitability has deteriorated.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -242 B) & Financial Cash Flow (¥ -93 B) is a minus, Operating Cash Flow (¥ 100 B) is a plus,

Dividend
Under the situation of Net Income (¥ 67 B) & Operating Cash Flow (¥ 100 B) , Dividend (¥ -57 B) is paid.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 122 B) is first term Net Income (¥ 170 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (12.54％) is first term Net Profit Margin (17.71％) less , there is a possibility that the profitability has deteriorated.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -31 B) & Financial Cash Flow (¥ -85 B) is a minus, Operating Cash Flow (¥ 150 B) is a plus,

Dividend
Under the situation of Net Income (¥ 122 B) & Operating Cash Flow (¥ 150 B) , Dividend (¥ -56 B) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 974 B) is first term (¥ 965 B) more, however Operating Cash Flow (¥ 150 B) is first term (¥ 197 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -28 B) & Financial Cash Flow (¥ -184 B) is a minus, Operating Cash Flow (¥ 197 B) is a plus,

Dividend
Under the situation of Net Income (¥ 170 B) & Operating Cash Flow (¥ 197 B) , Dividend (¥ -58 B) is paid.

Credit Rating (Bankruptcy Risk): アステラス製薬 (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	CCC	Credit is fragile, and depended on biz environs.	¥ 623 B 1.63%	¥ 143 B 120.77%	¥ 118 B 212.07%

Financial Timeline

Date	-  (First quarter )	-  (Second quarter )	-  (Third quarter )	2013-03-31  (Annual )
Credit Rating	-	-	-	CCC
Total Assets	-	-	-	¥ 914 B
Net Assets	-	-	-	¥ 803 B

Financial Statement Risk Analysis: アステラス製薬 (Annual ) (Non-Consolidated )

[Date: 2013-03-31]  Danger : Warning : Caution : Good

Stated Capital less
As compared with the first term of Stated Capital (¥ 103 B), Stated Capital (-) is less than 10%, , there is a possibility that the management situation is extremely severe.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 37 B) is first term Net Income (¥ 43 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (6.16％) is first term Net Profit Margin (7.23％) less , there is a possibility that the profitability has deteriorated.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 72 B) is Sales first term ratio (¥ 5 B) more , there is a possibility that the non-performing asset was increased.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Management Risk (*Sales is decrease )
Sales (¥ 608 B) is first term Sales (¥ 634 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ 43 B) is first term Net Income (¥ 74 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (7.23％) is first term Net Profit Margin (11.78％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 43 B) & Operating Cash Flow (-) , Dividend (¥ -57 B) is paid.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Sales is decrease )
Sales (¥ 634 B) is first term Sales (¥ 636 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ 74 B) is first term Net Income (¥ 107 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (11.78％) is first term Net Profit Margin (16.87％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 74 B) & Operating Cash Flow (-) , Dividend (¥ -56 B) is paid.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 107 B) & Operating Cash Flow (-) , Dividend (¥ -58 B) is paid.

Related Information: アステラス製薬 (Annual )

Statement Type

Annual : アステラス製薬

First quarter : アステラス製薬

Second quarter : アステラス製薬

Third quarter : アステラス製薬

Analysis Menu

Outline : アステラス製薬

Statement : アステラス製薬

Rating : アステラス製薬

Indicator : アステラス製薬

Download : アステラス製薬

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo中央区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
アステラス製薬	4503	TSE 1st	Chemicals	3	Annual	A

Related Company

東京応化工業 (Sales ¥ 72 B)

Aica Kogyo (Sales ¥ 101 B)

Fuso Pharmaceutical Industries (Sales ¥ 48 B)

Mitsubishi Tanabe Pharma (Sales ¥ 419 B)

Kao (Sales ¥ 1.0 T)

富士製薬工業 (Sales ¥ 25 B)

アステラス製薬 (Sales ¥ 1.0 T)

Kuraray (Sales ¥ 369 B)

Takeda Pharmaceutical (Sales ¥ 1.5 T)

キッセイ薬品工業 (Sales ¥ 62 B)

Hitachi Chemical (Sales ¥ 464 B)

Sekisui Chemical (Sales ¥ 1.0 T)

MANDOM (Sales ¥ 60 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .